Navigation Links
BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
Date:10/3/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, Oct. 3 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's U.S. pivotal phase III MAESTRO-03 trial of dirucotide (MBP8298) in patients with secondary progressive MS has completed a safety analysis and recommended that the trial continue as per the protocol.

This was the third of several regularly scheduled reviews by the DSMB that will occur over the duration of the trial. The purpose of the DSMB is to provide objective, independent safety monitoring of the trial.

About MAESTRO-03

----------------

The MAESTRO-03 U.S. pivotal phase III clinical trial is a randomized, double-blind study that has completed recruitment of approximately 510 patients at 68 clinical sites who will be administered either dirucotide (MBP8298) or placebo intravenously every six months for a period of two years. The primary clinical endpoint for the trial is defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded Disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes (up to 75% of all MS patients are HLA-DR2 and/or HLA-DR4 positive).

About BioMS Medical Corp.

-------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide (MBP8298), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... NDA with FDA in Early to Mid-2009 , , WOOD... Strativa Pharmaceuticals, the proprietary product...NYSE: PRX ) today announced that its development...letion of all pivotal bioequivalence studies for a...tron thin film product is being developed for the ...
(Date:12/2/2008)...., Dec. 2 GeneGo, Inc., the leadin...hat Burnham has become a certified GeneGo Center o...ution-wide access to GeneGo,s MetaCore data analys...ham institute is a world-class biomedical research...ies throughout many departments, including researc...
(Date:12/2/2008)..., Israel, December 2 InSightec Ltd... Magnetic Resonance-guided Focused,Ultrasound (MR...l to be an,effective noninvasive pain-relieving t... (bone metastases). The results of a 31 patient st...als of Surgical Oncology, while data from an,elev...
(Date:12/2/2008)...OLIS, France, December 2 ...unced it has signed an agreement with,DSM for the...drug substance,(or API, active pharmaceutical ing...nal product and the first compound in the,Cycloox...lass of,anti-inflammatory agents, which recently ...
Breaking Biology Technology:Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 3New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 4NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4
..., , , , , , Multiporator ... , , , , Trans... 915.508 12/2001 , , , , ... , Microorganism , Bruce...ll type , Bacteria, gram negative, ...
... , , , , , , , Ni...e Wagner , Nicole Passaretti, Vincent Pre...stbury, NY , Susanne WagnerEppendorfNethele... , , , Plasmids are naturally occur... cell, which can replicate independently but (usua...
..., , , , , , Multiporator ... , , , , Trans... 915.539 04/2002 , , , , ... , Microorganism , Actin..., Cell type , Bacteria, gram...
..., , , , , , Other importan..., , , , , , , ...lse length , , Number of ,... , of the electroporation buffer , ... Influence , of temperature ,...
Other Biology Technology:Brucella abortus 2Efficient Recovery of Ultrapure Plasmid DNA 2Efficient Recovery of Ultrapure Plasmid DNA 3Efficient Recovery of Ultrapure Plasmid DNA 4Actinobacillus pleuropneumoniae 2
(Date:12/2/2008)...e in German . ,, Where would we be witho...r, for that matter, to forget irrelevant details? ...unication units, called synapses, we are good at b...se was believed to play an active role in this reo...rlie our ability to learn but also to forget. An i...
(Date:12/1/2008)...nimals find their way back to their birthplace to ...s of open ocean has mystified scientists for more ...rsity of North Carolina at Chapel Hill think they ...e beginning of their lives, salmon and sea turtles...d "imprint" on it, according to a new theory in th...
(Date:12/1/2008)...ts around the world may benefit from a powerful ne...elp them to home in on the parts of proteins most ..., associate professor of pathology and of genetics...cently launched the novel bioinformatics tool, whi...he role different proteins play in a wide array of...
(Date:12/1/2008)... Sciences will hold a colloquium to examine what l... niches of organisms. Leading researchers and stud...erns of distribution and even evolution from the p...s, and biodiversity informatics dealing with micro...oquium series, the event will take place at the Ar...
Breaking Biology News(10 mins):It takes 2 to tango 2It takes 2 to tango 3No place like home: New theory for how salmon, sea turtles find their birthplace 2No place like home: New theory for how salmon, sea turtles find their birthplace 3Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Many Ignore Symptoms of Bladder Trouble 29909 1Many Ignore Symptoms of Bladder Trouble 29909 2Putting a new spin on current research 9219 1Genetics of aging and cancer resistance 29903 1TRIDELITY Display Solutions Partners With Two Of The World 26apos 3Bs Leading Imaging Software Companies 9216 1TRIDELITY Display Solutions Partners With Two Of The World 26apos 3Bs Leading Imaging Software Companies 9216 2TRIDELITY Display Solutions Partners With Two Of The World 26apos 3Bs Leading Imaging Software Companies 9216 3
...mary strategies for regulating its genome is a kin... molecules called microRNAs, or miRNAs. First obse...to inactivate messenger RNA, itself responsible fo... been eager to know more about miRNAs, clearly imp... gone unnoticed for so long. How are they produced...
...lts from a study in Botswana, Harvard School of Pu...h HIV-1 subtype C in resource-poor settings, who r...omparable results to those in the developed world.... infrastructure help ensure this success, accordin...Journal of Acquired Immune Deficiency Syndromes (J...
...thogens, the Chlamydiae know us very, very well. T...ls half a billion years ago by reprogramming cellu...dial infections are responsible for a range of ail...ical pneumonias to chronic severe disorders such a... The Centers for Disease Control says that Chlamyd...
... reported this week in Current Biology, tsunami da...e 2004 Sumatra-Andaman earthquake was occasionally...ly when compared to damage from chronic human misu...tsunami of December 26, 2004, a team of ecologists...tion Society-Indonesia Program, and Syiah Kuala Un...
Other Biology News:Twin molecular scissors link creation of microRNAs with gene-silencing 2Largest computational biology simulation mimics life’s most essential nanomachine 2Chlamydia parasite lives off our fat 2
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody
...hthoyl-VF-CHO White lyophilized solid. PROTECT F...ble, reversible inhibitor of γ-secretase. Eq...ED 50 = 2.6 μM) and Aβ x-42 (ED 50 = 2....he Amyloid Precursor Protein Swedish mutants. Pur...
Mlu I from New England Biolabs
Corticoliberin
Biology Products: